Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer (Q71810507)
Jump to navigation
Jump to search
scientific article published on 01 November 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer |
scientific article published on 01 November 1996 |
Statements
Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer (English)
Gisselbrecht C
Extra JM
Lotz JP
Devaux Y
Janvier M
Peny AM
Guillevin L
Bremond D
Delain M
Herbrecht R
Lepage E
1 November 1996